BACKGROUND: Twenty-seven percent of neuroendocrine tumors (NETs) are associated with distant metastases, and in some patients, the primary site is unknown. Orthopedia homeobox protein (OTP) has been described as a useful marker for lung carcinoids (LCs) and for separating low-grade typical carcinoids (TCs) from intermediate-grade atypical carcinoids (ACs) in resection specimens. This study evaluated OTP, thyroid transcription factor 1 (TTF-1), and Ki-67 expression in fine-needle aspiration (FNA) samples of various NETs. METHODS: A search for NETs diagnosed via FNA with subsequent resection was performed. Cell block sections were stained for OTP, TTF-1, and mindbomb E3 ubiquitin protein ligase 1 (Mib-1). Nuclear expression for OTP and TTF-1 was considered positive. Nuclear Ki-67 staining was reported as a percentage. Results were correlated with the grade and primary site for resection specimens. RESULTS: Sixty-three FNA samples of NETs were identified: 14 liver samples, 14 pancreatic samples, 13 lymph node samples, 12 lung samples, 3 retroperitoneum samples, 2 small intestine samples, and 5 other samples. OTP was positive in 12 of 63 NETs (19%) from the following sites: lung (n 5 8), liver (lung primary; n 5 2), skin (n 5 1), and lymph node (lung primary; n 5 1). In welldifferentiated NETs, only LCs were OTP-positive, whereas TTF-1 was positive in LCs and nonlung NETs (67% vs 7%). Within the LC category, OTP was positive in 100% of the TCs versus 17% of the ACs. CONCLUSIONS: OTP is specific for LCs because well-differentiated nonlung NETs are negative for OTP. OTP preferentially stains TCs over ACs. In welldifferentiated NETs, OTP staining is highly specific for LCs, and in combination with a low Ki-67 index, it suggests a pulmonary TC. Cancer Cytopathol 2018;126:236-42.
INTRODUCTION
The 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart 1 subclassifies well-differentiated lung neuroendocrine tumors (NETs) into low-grade typical carcinoids (TCs) and intermediate-grade atypical carcinoids (ACs). Lymph node and distant metastases are more common in ACs than TCs, and there is a significant difference in 5-year survival rates between patients with TCs (90%) and patients with ACs (60%). The mitotic index and the TNM stage are the most important predictive factors for patient outcomes. A TC is defined as a NET with less than 2 mitoses/mm 2 , no necrosis, and a tumor size greater than 0.5 cm. ACs are carcinoid tumors with 2 to 10 mitoses/mm 2 and/or foci of necrosis. The heterogeneity of the mitotic count and the often very focal nature of the punctate necrosis may be difficult to appreciate in small samples, and this makes the separation of TCs from ACs difficult in biopsy specimens.
In the metastatic setting, which is observed in approximately 27% of patients with a NET, the primary site remains unknown or uncertain even after extensive diagnostic workup.
2 Some patients present with symptoms related to the overproduction of biologically active hormones and peptides, and for these patients, serological studies to detect these hormones and peptides can help in identifying the primary site. Organ-specific immunohistochemistry (IHC) markers, such as thyroid transcription factor 1 (TTF-1), glucagon, gastrin, and serotonin, can also be applied to tissue samples to aid the diagnostic workup. 3 Additional IHC markers, including paired box 8 (PAX8; via a polyclonal antibody to PAX8), NK6 homeobox 1 (NKX6.1), and caudal type homeobox 2 (CDX2), have been identified as potential markers for helping to determine the primary site, although many of these IHC stains are specific to well-differentiated gastrointestinal and pancreatic NETs. Of the aforementioned IHC stains, only TTF-1 is a useful confirmatory stain for pulmonary carcinoids. Although TTF-1 is relatively specific for pulmonary carcinoids, especially if high-grade neuroendocrine carcinomas such as small cell carcinomas and medullary thyroid carcinomas have been excluded from the differential diagnosis, only approximately 28% to 37% of TCs and 20% to 32% of ACs express TTF-1 with a higher frequency rate in peripheral tumors versus centrally located tumors, [4] [5] [6] and this indicates that TTF-1 is a highly specific but relatively less sensitive marker in the diagnostic workup of metastatic well-differentiated NETs. Orthopedia homeobox protein (OTP) is a transcription factor with a well-defined role in embryonic neurodevelopment. Previous studies have shown OTP expression in pulmonary neuroendocrine hyperplasia (reactive and preneoplastic) as well as TCs, for which it has been proven to be a useful diagnostic and prognostic marker. 7 OTP expression in TCs is associated with poor clinical outcomes and disease progression. Positive nuclear staining for OTP is reported to have high sensitivity and specificity (80.2% and 99.4%, respectively) for the diagnosis of pulmonary carcinoid tumors, especially TCs. 8 On the other hand, cytoplasmic granular staining does not reflect OTP expression, and it is a common finding in various tumors and organs and should not be regarded as positive. Several other prognostic markers have been evaluated for TCs, including CD44, an adhesion molecule known to be associated with tumor cell invasion and metastasis. A study by Papaxoinis et al 8 evaluated the expression of CD44 and OTP. In their study, only nuclear OTP staining showed a correlation with CD44 expression, TC histology, TTF-1 expression, and relapse-free survival. Cytoplasmic OTP staining, on the other hand, showed no prognostic significance and no association with CD44 expression or correlation with the tumor histologic subtype.
The clinical prognosis and treatment options for patients with NETs are based on histologic features and measurements of a proliferative index, which can be challenging because of tumor heterogeneity and the different methodology used to determine the mitotic index. 9, 10 Fine-needle aspiration (FNA) is a cost-effective, minimally invasive diagnostic procedure for the diagnostic workup of primary and metastatic tumors. After an assessment of specimen adequacy, additional material can be collected for a cell block preparation, or core biopsy can be requested if ancillary studies are anticipated in the diagnostic workup.
The goals of our study were to evaluate OTP expression in FNA samples of metastatic NETs of various locations and to correlate OTP results with TTF-1 and Ki-67 expression. In addition, we assessed the utility of these 3 markers in FNA samples for separating lung carcinoids (LCs) from nonlung and lung NETs and for further separating TCs from ACs.
MATERIALS AND METHODS
After institutional review board approval, the anatomic pathology database was searched for patients diagnosed with NETs on FNA specimens who subsequently underwent surgical resection. Five-micrometer sections from each formalin-fixed, paraffin-embedded FNA cell block were tested for OTP expression with a rabbit anti-OTP polyclonal immunoglobulin G antibody (HPA039365; 1:800; Sigma Aldrich, St. Louis, Missouri) and the EnVision FLEX dual-link system (Dako, Carpinteria, CA), which is a horseradish peroxidase-labeled polymer with heat-induced antigen retrieval. Sections were deparaffinized and rehydrated with deionized water. They were then heated in a citrate buffer (pH 6.0) with an electric pressure cooker for 3 minutes at 12 to 15 psi and 1208C and cooled for 10 minutes before immunostaining. All slides were loaded onto the automated system (Autostainer Link 48; Dako) and exposed to 3% hydrogen peroxide for 5 minutes, and they were incubated with the primary antibody for 30 minutes, with the labeled polymer (the EnVision FLEX dual-link system) for 30 minutes, with 3, for 15 minutes and with the postprimary polymer for 8 minutes and were blocked with 3% hydrogen peroxide for 5 minutes, with DAB as a brown chromogen for 5 minutes, and with hematoxylin as a counterstain for 5 minutes. Incubations were performed at room temperature, and the samples were washed with trishydroxymethylaminomethanebuffered saline. Coverslipping was performed with the Tissue-Tek SCA coverslipper (Sakura Finetek USA, Inc, Torrance, California). A resection specimen of a known primary lung TC was used as a positive control for OTP, a lung adenocarcinoma specimen was used for TTF-1, and a tonsil specimen was used for Ki-67. Because cell block samples often are limited in cellularity, any percentage or intensity of nuclear OTP and TTF-1 expression was considered positive. The Ki-67 index was manually calculated as the percentage of positive nuclear staining in tumor cells among 500 total tumor cells counted within hot spots. Results were correlated with the final diagnosis for resection specimens, the grade, and the primary site.
RESULTS
Sixty-three FNA samples of NETs with corresponding surgical resection specimens were identified. Patients' ages ranged from 26 to 91 years (mean, 61 years), and there were 24 males and 39 females. FNA biopsy sites included the following: liver (14 of 63 or 22.2%), pancreas (14 of 63 or 22.2%), lymph node (13 of 63 or 20.6%), lung (12 of 63 or 19.0%), retroperitoneum (3 of 63 or 4.8%), small intestine (2 of 63 or 3.2%), and other sites such as the abdomen, mesentery, skin, stomach, and umbilicus (5 of 63 or 7.9%). Table 1 summarizes specimens that were included in the study by the FNA site, by the origin of the NET based on the follow-up surgical specimens, and by the histologic grade of the NET reported for the original cytology specimen. The grading of NETs on FNA samples was performed on the basis of cytomorphology and the quantification of nuclear Ki-67 staining via the counting of 500 tumor cells.
Of the 63 samples originally included in the study, we excluded 4 because of either an insufficient number of tumor cells left in the archival paraffin block (1 pancreatic FNA) or a failure to satisfy the criteria for a welldifferentiated NET (3 cases: 2 Merkel cell carcinomas and 1 high-grade NET of the lung with a Ki-67 index of 50%). OTP was positive in 10 of the remaining 59 NETs (16.9%). The positive samples were all lung NETs from the following sites: lung (n 5 7), liver (metastasis from a lung primary; n 5 2), and lymph node (metastasis from a lung primary; n 5 1). The negative cases (49 of 59 or 83%) included all pancreatic primary NETs (13 of 13 or 100%), liver FNA samples (12 of 14 or 85.7%), lymph node samples (12 of 13 or 92.3%), lung FNA samples (4 of 11 or 36.4%), retroperitoneum samples (3 of 3 or 100%), and samples from other sites such as the small intestine, mesentery, stomach, and umbilicus (5 of 5 or 100%). When OTP staining was evaluated on the basis of the primary NET site, 10 of 15 primary well-differentiated pulmonary NETs (67%) were positive for OTP, whereas none of the extrapulmonary or unknown primary NETs (0 of 44 or 0%) were positive for this marker (Table 2) . Therefore, the sensitivity of OTP for establishing the lung as a primary site for a well-differentiated NET is 66.7%, whereas its specificity is 100%; the positive and negative predictive values are 100% and 89.9%, respectively. The combination of TTF-1 and OTP positivity, however, decreases the sensitivity to 40% for the detection of welldifferentiated NETs of a pulmonary origin, whereas the specificity remains the same (100%). Furthermore, our results show that only LCs were OTP-positive, whereas TTF-1 was positive in both LCs and nonlung NETs (67% vs 7%; Table 2 and Fig. 1 ). Within the LC category, OTP was positive in 100% of the TCs versus 17% of the ACs; it showed a sensitivity of 100%, a specificity of 83.3%, a positive predictive value of 90%, and a negative predictive value of 100% for the diagnosis of a TC of a lung origin.
DISCUSSION
The differential diagnosis of a well-differentiated neuroendocrine neoplasm/proliferation arising from a pulmonary origin ranges from neuroendocrine hyperplasia to a carcinoid tumorlet to a TC to an AC. Differentiating the precursor lesion of neuroendocrine hyperplasia from a carcinoid tumorlet is based on the presence of invasion through the bronchiolar basement membrane, whereas differentiating a carcinoid tumorlet from an LC is based on size criteria with a 0.5-cm cutoff point. 1 The diagnosis of pulmonary neuroendocrine tumorlets on FNA is even more challenging. Because of their small size, they are often not the primary target of image-guided FNA. On the other hand, because they might be associated with other nonneoplastic lung lesions, 11 they can be sampled incidentally and overinterpreted as TCs or ACs. 12 Therefore, distinguishing these precursor lesions from carcinoid tumors on FNA samples or small biopsies always requires good clinical, endoscopic, and radiological correlation. When these precursor lesions are excluded from the differential diagnoses, LCs can be separated into low-grade TCs and intermediate-grade ACs on the basis of the mitotic count and/or the presence of necrosis; however, because of the definitional criteria in the grading of well-differentiated NETs of the lung and the heterogeneity of both the mitotic count and the focality of the characteristic punctate necrosis of intermediate-grade ACs, definitive grading of well-differentiated neuroendocrine neoplasms of the lung on biopsy specimens is discouraged. 13 In addition, when metastatic disease is clinically suspected because of either the location of the tumor (eg, liver) or the existence of multiple tumor nodules in the lung, the determination of the primary site solely on the basis of morphological characteristics is difficult because of the significant morphological similarity between well-differentiated NETs of pulmonary and extrapulmonary origins.
14 Therefore, an IHC stain specific for welldifferentiated NETs, which could provide information on the primary site, histologic grade, and clinical prognosis and ultimately help with further treatment planning (the extent of surgery and systemic therapy), would be very valuable for both pathologists and clinicians. Prior studies have evaluated various IHC markers, including TTF-1, polyclonal PAX8, CDX2, NKX6.1, and Ki-67, for determining the primary site and for tumor grading and classification of NETs. 4, [15] [16] [17] [18] [19] In these studies, a combination of TTF-1, CDX2, PAX8, and possibly NKX6.1 is useful for Abbreviations: AC, atypical carcinoid; OTP, orthopedia homeobox protein; TC, typical carcinoid; TTF-1, thyroid transcription factor 1. a Includes an undetermined primary site. b Well-differentiated neuroendocrine tumors from extrapulmonary sites have a variable Ki-67 labeling index, including <5% for pancreatic fine-needle aspirates, 3% for small bowel neuroendocrine tumors, <1% to 26% for neuroendocrine tumors diagnosed in liver fine-needle aspirates, and 1% to 26% for various lymph node fine-needle aspirates with metastatic neuroendocrine tumors.
differentiating primary well-differentiated pulmonary and gastrointestinal-tract NETs. Briefly, TTF-1 is useful for pulmonary carcinoids; CDX2 is useful primarily for midgut tumors; PAX8 (polyclonal) is useful for duodenal, pancreatic, rectal, gastric, and appendiceal primary sites; and NKX6.1 is useful for pancreatic tumors. Within this panel of IHC stains, the utility of TTF-1 for determining a pulmonary origin is limited in part by the relatively low sensitivity of the stain because only approximately onethird of pulmonary carcinoids will be positive for TTF-1. Hence, there is often a need for additional IHC stains to help with identifying the remaining two-thirds of the pulmonary carcinoids that are TTF-1-negative. In addition to providing information regarding the primary site of the tumor, an indication of the possible grade would be clinically informative. The grading of welldifferentiated NETs of the lung and gastrointestinal tract is somewhat similar and includes the use of a Ki-67 labeling index. 20 A Ki-67 labeling index with well-defined values is used to grade gastrointestinal NETs, 21 whereas a Ki-67 labeling index is used as a guideline in the grading of pulmonary NETs, including pulmonary carcinoids. In this study, we have shown that when it is combined with TTF-1, OTP is a useful marker for LCs in a small biopsy setting. OTP, a homeobox transcription factor that is important for the development of neuroendocrine hypothalamic neurons, has been determined to be expressed and to have a possible role in the extrahypothalamic neuroendocrine system on the basis of a gene expression profile screen of pulmonary carcinoids with good and poor prognoses. 7 We have also observed that OTP is preferentially expressed in well-differentiated pulmonary NETs versus extrapulmonary tumors (67% vs 0%), and this observation was described by Nonoka et al. 22 Similarly, we have observed that a subset of pulmonary carcinoids that are TTF-1-negative express OTP, and this suggests that OTP, in combination with TTF-1, is a valuable addition for the identification of pulmonary NET primaries, especially when metastatic disease is in the differential and TTF-1 is negative. In summary, our data, though limited by the number of primary well-differentiated lung NETs included in the study, show that OTP is a highly sensitive and specific marker of LCs and is preferentially expressed in TCs versus ACs. These findings are concordant with those previously reported by Nonaka et al 22 and Swarts et al. 7 Three of our cases (2 Merkel cell carcinomas and 1 high-grade NET of the lung) also showed strong nuclear OTP expression, which also has been reported by others. However, because our study focused on well-differentiated NETs, we did not include these cases in our final analysis. The results of our study highlight the potential role of OTP in the diagnostic workup of metastatic well-differentiated NETs because all specimens from extrapulmonary primary sites lacked OTP expression. In addition, none of the FNA-sampled NETs with an unknown primary site at the time of the initial diagnosis turned out to have a lung origin. Therefore, OTP IHC showed superior performance to TTF-1 in determining the site of origin of well-differentiated NETs because only 67% of LCs and 7% of nonlung NETs were positive for TTF-1.
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